Manulife (Manufacturers Life Insurance)’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$502K Sell
38,328
-18,660
-33% -$245K ﹤0.01% 2176
2025
Q1
$1.25M Buy
56,988
+16,818
+42% +$370K ﹤0.01% 1702
2024
Q4
$1.07M Buy
40,170
+1,760
+5% +$47K ﹤0.01% 1879
2024
Q3
$1.03M Buy
38,410
+44
+0.1% +$1.17K ﹤0.01% 1916
2024
Q2
$691K Buy
38,366
+7,786
+25% +$140K ﹤0.01% 2054
2024
Q1
$558K Buy
30,580
+13,322
+77% +$243K ﹤0.01% 2163
2023
Q4
$189K Sell
17,258
-662
-4% -$7.24K ﹤0.01% 2644
2023
Q3
$103K Buy
17,920
+192
+1% +$1.1K ﹤0.01% 2797
2023
Q2
$137K Buy
17,728
+3,294
+23% +$25.5K ﹤0.01% 2739
2023
Q1
$96.3K Hold
14,434
﹤0.01% 2751
2022
Q4
$129K Buy
14,434
+1,827
+14% +$16.3K ﹤0.01% 2726
2022
Q3
$124K Sell
12,607
-410
-3% -$4.03K ﹤0.01% 2749
2022
Q2
$104K Sell
13,017
-2,713
-17% -$21.6K ﹤0.01% 2896
2022
Q1
$153K Sell
15,730
-3,204
-17% -$31.1K ﹤0.01% 2860
2021
Q4
$289 Buy
+18,934
New +$289 ﹤0.01% 2622